Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
Deep Dive - Peripheral Vascular Clot Removal Systems
By
MedTech Outlook | Tuesday, May 26, 2026
Peripheral vascular clot removal is no longer viewed as a straightforward device purchase. Hospitals, ambulatory surgery centers and office-based labs are now weighing these systems against a much broader set of concerns that includes procedural control, treatment speed, staff familiarity and financial practicality.
Open surgery still plays an important role in many vascular cases, but it comes with operating room demands, recovery considerations and additional strain on patients. Drug-based thrombolytic therapy can help avoid surgery in some situations, yet bleeding risk, treatment timing and patient eligibility often limit how broadly those therapies can be used.
Mechanical clot-removal systems are increasingly positioned between those two approaches. But not every system is designed with the realities of peripheral vascular work in mind. Peripheral vessels can present long clot segments, varying clot consistency and smaller downstream anatomy where even minor embolization can quickly complicate a procedure.
That makes procedural control extremely important.
Healthcare leaders evaluating thrombectomy systems should pay close attention to how a device captures and removes clot while minimizing additional vessel stress. Systems that rely heavily on aspiration may raise concerns around blood loss during longer procedures. More aggressive mechanical approaches can introduce questions about vessel interaction, especially in delicate or distal anatomy.
The strongest systems tend to balance control with simplicity. Physicians need the ability to remove clot effectively, make repeated passes if necessary and maintain confidence that material is being captured rather than displaced downstream. Consistency matters because clot composition can vary significantly from one patient to another and even within the same vessel.
Workflow fit also carries major weight in purchasing decisions. Interventional teams work best with systems that feel intuitive and do not require extensive setup, complicated capital equipment or constant device exchanges during the procedure. In busy vascular labs, simplicity can directly influence adoption.
Devices that follow familiar interventional techniques are often easier for both physicians and technicians to integrate into routine practice. That matters not only for scheduled thrombectomy procedures but also during unexpected embolic events that occur in the middle of another intervention.
Training requirements are another practical concern. Systems that demand prolonged oversight or highly specialized handling can slow adoption, particularly in outpatient environments where staff efficiency is critical.
Economic pressure is also reshaping how these technologies are evaluated. More vascular procedures are shifting into ambulatory and office-based settings, where inventory management, disposable costs and procedural efficiency influence purchasing decisions just as much as clinical performance.
Healthcare organizations increasingly want systems that can be used across a range of clot types and vessel sizes without requiring multiple niche products for different presentations. Flexibility becomes especially important in smaller programs and international markets where infrastructure and budget constraints are tighter.
The strongest value often comes from systems that combine procedural control, operational simplicity and adaptability across care settings rather than forcing clinicians to compromise between them.
iCHOR Vascular stands out in this category because it approaches mechanical thrombectomy with a design philosophy rooted in familiar surgical concepts adapted for endovascular use. Its iSWEEP Mechanical Thrombectomy System is intended for the non-surgical removal of emboli and thrombi from peripheral blood vessels and is available in both arterial and venous configurations.
The system combines an introducer sheath with an occlusion balloon, a guide catheter featuring an expandable nitinol funnel and a compliant balloon catheter designed to sweep clot material into the funnel for controlled removal.
For hospitals, outpatient vascular programs and physician groups looking for clot-removal systems that prioritize controlled capture, straightforward setup and flexibility across treatment environments, iCHOR Vascular offers a practical and highly focused approach to peripheral thrombectomy.
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
